Zhejiang Huahai Pharmaceutical Co., Ltd (SHA: 600521), a leading Chinese pharmaceutical company, has unveiled plans for a private placement of 148,000,000 shares, raising a total of RMB 1.21 billion (approximately USD 170 million). The capital raised from this private placement is earmarked for the construction of digital intelligent manufacturing facilities for pharmaceutical preparations and to bolster the company’s supplementary working capital.
This strategic move underscores the company’s commitment to enhancing its manufacturing capabilities through digital transformation and expanding its operational capacity to meet growing market demands.- Flcube.com
